Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5M | $2.4M | $2.3M | $2.2M | $2.1M | $2.0M | $1.8M | $2.0M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $2.5M | $2.4M | $2.3M | $2.2M | $2.1M | $2.0M | $1.8M | $2.0M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $2.2M | $2.2M | $2.0M | $2.0M | $1.9M | $1.8M | $1.6M | $1.7M |
| EBITDA | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | $2.2M | $241.8K | $1.7M | $2.6M | $1.5M | $3.2M | −$315.2K | −$3.9M |
| Net margin | 89.2% | 10.0% | 73.5% | 117.7% | 69.2% | 159.0% | -17.1% | -199.1% |
| EPS (diluted) | 0.56 | 0.06 | 0.42 | 0.65 | 0.38 | 0.83 | -0.08 | -0.99 |
Annual figures · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| DRNYXBNY Mellon New York Tax Exempt Bond Fund, Inc. | $13.53 | -0.07% | $1.0B | — |
| DFCIXDelaware SMID Cap Growth Fund Class A | $16.08 | -0.74% | $1.1B | — |
| EOMYXAllspring Discovery All Cap Growth - Admin | $59.05 | +1.22% | $793M | — |
| IVWAXIVA Worldwide Fund Class A | $17.14 | -1.45% | $991M | — |
| MCBIXBMO TCH Core Plus Bond Fund Class I Shares |
No one on the platform currently holds DRNYX.
No tracked institution reports a position in DRNYX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2024-05-31 | $0.0191 | 2024-05-31 |
| 2024-05-15 | $0.0184 | 2024-05-15 |
| 2024-04-30 | $0.0300 | 2024-04-30 |
| 2024-02-29 | $0.0289 | 2024-02-29 |
| 2024-01-31 | $0.0292 | 2024-01-31 |
| 2023-12-30 | $0.0316 | 2023-12-30 |
| 2023-11-30 | $0.0307 | 2023-11-30 |
| 2023-10-31 | $0.0331 | 2023-10-31 |
| 2023-09-30 | $0.0295 | 2023-09-30 |
| 2023-08-31 | $0.0313 | 2023-08-31 |
| 2023-07-29 |
No one on the platform has traded DRNYX yet.
| $11.62 |
| +0.00% |
| $1.2B |
| — |
| MCYBXBMO TCH Core Plus Bond Fund Class Y Shares | $11.63 | +0.00% | $915M | — |
| MTXVXMainStay Income Builder Fund Class R3 | $19.06 | +0.37% | $1.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
| $0.0309 |
| 2023-07-29 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.